Russian Health Ministry Opposes Ban on E-Liquid Sales

Regulations by 2FIRSTS.ai
Nov.24.2023
Russian Health Ministry Opposes Ban on E-Liquid Sales
Russia's health ministry opposes a ban on the sale of e-liquids containing nicotine, citing potential infringement on citizens' health protection law.

According to a report by the Russian news agency TASS on November 24th, the Russian Ministry of Health has stated that it does not support a ban on the sale of e-liquids containing and not containing nicotine.

 

The department's submitted motion to withdraw the bill draft argues that it could potentially violate the concept of the Citizen Health Protection Act and result in legal conflicts and ambiguous interpretations.

 

According to reports, the Ministry of Health has also pointed out that by 2023, the estimated tax revenue from the production and import of nicotine-containing e-liquids in Russia will be 3.6 billion rubles.

 

The department predicts that tax revenues will increase in the coming years, reaching 12.1 billion, 12.6 billion, and 13.1 billion rubles in 2024, 2025, and 2026 respectively.

 

The Ministry of Health believes that if retail is banned, it will result in a loss of over 12 billion rubles (CNY 964 million) in tax revenue annually, with no clear sources for compensation at present.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Lao Shuts Down Nearly 300 Online Vape Stores in Joint Crackdown with WHO and Meta
Lao Shuts Down Nearly 300 Online Vape Stores in Joint Crackdown with WHO and Meta
In a coordinated effort with the World Health Organization (WHO) and Meta, the Lao Ministry of Health has taken 288 online e-cigarette stores with more than 759,599 members offline, reinforcing the country’s total ban on e-cigarettes under the National Tobacco Control Law.
Nov.20 by 2FIRSTS.ai
Nicoventures Granted Rehearing After Philip Morris Challenge Rejected
Nicoventures Granted Rehearing After Philip Morris Challenge Rejected
Nicoventures Trading Ltd., a subsidiary of British American Tobacco (BAT), has won an appeal at the European Patent Office (EPO), convincing the appellate board that examiners had violated its right to be heard by failing to review all of its submissions.
Dec.09 by 2FIRSTS.ai
China’s E-Cigarette Exports USD 1.096 billion in November, UK and South Korea Offset U.S. Decline
China’s E-Cigarette Exports USD 1.096 billion in November, UK and South Korea Offset U.S. Decline
China’s e-cigarette exports edged lower in November 2025, totaling USD 1.096 billion, down 0.2% month-on-month, as a decline in shipments to the United States was partially offset by stronger demand from the United Kingdom, Germany and South Korea, according to data released by the General Administration of Customs of China.
Dec.22 by 2FIRSTS.ai
Altria CEO Billy Gifford to Retire; Sal Mancuso Named Successor
Altria CEO Billy Gifford to Retire; Sal Mancuso Named Successor
Altria Group, Inc. (NYSE: MO) announced that CEO Billy Gifford will retire at the conclusion of the 2026 Annual Meeting of Shareholders on May 14, 2026, after more than 30 years with the company. The Board of Directors has elected Salvatore (Sal) Mancuso, Altria’s current Executive Vice President and CFO, to succeed him as CEO.
Dec.12 by 2FIRSTS.ai
Malaysia’s Cabinet Agrees in Principle to Nationwide Vape Ban
Malaysia’s Cabinet Agrees in Principle to Nationwide Vape Ban
Malaysia is accelerating efforts toward a nationwide ban on vaping, with the Health Ministry aiming to finalise the policy by 2026. Health Minister Dzulkefly Ahmad said the Cabinet has already agreed in principle to move toward a ban, stressing that the issue is no longer whether vaping will be banned, but when.
Dec.16 by 2FIRSTS.ai
Interpreting FDA’s on! PLUS Authorization: What the Agency’s Press Release Reveals About Its Nicotine Pouch Review Model
Interpreting FDA’s on! PLUS Authorization: What the Agency’s Press Release Reveals About Its Nicotine Pouch Review Model
The U.S. Food and Drug Administration has confirmed that six on! PLUS nicotine pouch products have received Marketing Granted Orders (MGO) through the PMTA pathway. The authorizations were completed under the agency’s nicotine pouch review pilot program in “record time,” with the FDA citing lower levels of harmful constituents while stressing that the decision applies only to the specified products and does not mean they are safe or FDA approved.
Regulations
Dec.20